HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era

被引：0
|
作者：
Shaffer, Ashton [1 ]
Cash, Ayla [1 ]
Anjum, Saad [1 ]
Gurakar, Ahmet [1 ]
Durand, Christine [1 ]
Segev, Dorry [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-133
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [1] HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era
    Shaffer, A.
    Cash, A.
    Anjum, S.
    Segev, D.
    Durand, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [2] Impact of DAA Treatment on Graft Fibrosis in HCV Positive Liver Transplantation
    Wellington, Jennifer
    Ma, Andrew
    Kottilil, Shayam
    Husson, Jennifer
    Wilson, Eleanor
    Bruno, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 31 - 31
  • [3] Impact of DAA Treatment on Craft Fibrosis in HCV Positive Liver Transplantation
    Wellington, J.
    Ma, A.
    Kottilil, S.
    Husson, J.
    Wilson, E.
    Bruno, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1123 - 1123
  • [4] Treatment of HCV in the DAA era: the impact of a multidisciplinary team
    Chervenak, Amy E.
    Aqel, Bashar
    Byrne, Thomas J.
    Carey, Elizabeth J.
    Rakela, Jorge
    Harte, Lorrie A.
    Gallegos-Orozco, Juan F.
    Sapola, Amy M.
    Vargas, Hugo E.
    HEPATOLOGY, 2012, 56 : 228A - 228A
  • [5] Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era
    Piecha, Felix
    Gaenssler, Jan-Michael
    Ozga, Ann-Kathrin
    Wehmeyer, Malte H.
    Kluwe, Johannes
    Lampalzer, Sibylle
    Creutzfeldt, Anna Maria
    Buescher, Gustav
    Horvatits, Thomas
    Sterneck, Martina
    Pischke, Sven
    Lohse, Ansgar W.
    Schulze zur Wiesch, Julian
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (07) : 840 - 848
  • [6] Liver disease in HIV-infected subjects in the post-HCV DAA treatment era
    Busca, C.
    Olveira, A.
    Valencia, E.
    Moreno, V.
    Martin Carbonero, L.
    Montejano, R.
    Perez-Valero, I.
    Bernardino, J. I.
    Mican, R.
    De Miguel, R.
    Arnalich, F.
    Arribas, J. R.
    Gonzalez, J.
    Montes, M. L.
    HIV MEDICINE, 2019, 20 : 295 - 296
  • [7] Treatment and re-treatment results of HCV patients in the DAA era
    Piecha, Felix
    Gaenssler, Jan-Michael
    Ozga, Ann-Kathrin
    Wehmeyer, Malte H.
    Dietz, Julia
    Kluwe, Johannes
    Laschtowitz, Alena
    von Felden, Johann
    Sterneck, Martina
    Jordan, Sabine
    Pischke, Sven
    Lohse, Ansgar W.
    zur Wiesch, Julian Schulze
    PLOS ONE, 2020, 15 (05):
  • [8] Treatment of HIV/HCV co-infection in the DAA era
    Rockstroh, J. K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S20 - S21
  • [9] The Declining Burden of HCV on the Liver Transplant Waitlist associated with the DAA era
    Cholankeril, George
    March, Katherine L.
    Yoo, Eric R.
    Li, Andrew A.
    Cholankeril, Rosann
    Perumpail, Ryan B.
    Satapathy, Sanjaya K.
    Ahmed, Aijaz
    HEPATOLOGY, 2017, 66 : 72A - 72A
  • [10] Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?
    Bourliere, Marc
    LIVER INTERNATIONAL, 2012, 32 (07) : 1033 - 1036
12345